| RS118203997 |
PALB2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group N, Hereditary cancer-predisposing syndrome |
| RS118203998 |
PALB2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group N, Familial cancer of breast |
| RS118203999 |
PALB2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group N, Hereditary cancer-predisposing syndrome |
| RS118204000 |
SEC23A
|
Health Risk |
Pathogenic |
Craniolenticulosutural dysplasia, Craniolenticulosutural dysplasia |
| RS118204001 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS118204003 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS118204004 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS118204005 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, MAT1A-related disorder |
| RS118204006 |
MAT1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS118204007 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS118204008 |
CYP27B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS118204009 |
CYP27B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitamin D-dependent rickets, type 1 |
| RS118204010 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS118204011 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1A |
| RS118204014 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS118204015 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS118204016 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Abnormal circulating enzyme concentration |
| RS118204017 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, ACADVL-related disorder |
| RS118204018 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS118204020 |
L2HGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
L-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria |
| RS118204021 |
L2HGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
L-2-hydroxyglutaric aciduria, L2HGDH-related disorder |
| RS118204022 |
WDR36
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 1, open angle |
| RS118204024 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS118204025 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS118204026 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS118204027 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Nonsyndromic genetic hearing loss |
| RS118204028 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS118204029 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS118204030 |
TRIOBP
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS118204031 |
TRIOBP
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 28, Autosomal recessive nonsyndromic hearing loss 28 |
| RS118204032 |
NEK8
|
Health Risk |
Pathogenic |
Nephronophthisis 9, Nephronophthisis 9 |
| RS118204034 |
MESP2
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 2, autosomal recessive |
| RS118204035 |
MESP2
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 2, autosomal recessive |
| RS118204039 |
FECH
|
Health Risk |
Pathogenic |
Protoporphyria, erythropoietic |
| RS118204040 |
FECH
|
Health Risk |
Pathogenic |
Protoporphyria, erythropoietic |
| RS118204041 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 11, Primary ciliary dyskinesia |
| RS118204042 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 11, Primary ciliary dyskinesia |
| RS118204043 |
RSPH4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia 11, Primary ciliary dyskinesia |
| RS118204044 |
MMADHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Homocystinuria-megaloblastic anemia cblD type, Methylmalonic aciduria and homocystinuria type cblD |
| RS118204045 |
MMADHC
|
Health Risk |
Pathogenic |
Homocystinuria-megaloblastic anemia cblD type, Homocystinuria-megaloblastic anemia cblD type |
| RS118204046 |
MMADHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Homocystinuria-megaloblastic anemia cblD type, Methylmalonic aciduria and homocystinuria type cblD |
| RS118204047 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Isolated methylmalonic aciduria cblD type |
| RS118204048 |
MMADHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS118204049 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS118204050 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS118204051 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 9, COACH syndrome 1 |
| RS118204052 |
CC2D2A
|
Health Risk |
Likely pathogenic |
Joubert syndrome 9, COACH syndrome 2 |
| RS118204053 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome 9, Inborn genetic diseases |
| RS118204055 |
RBM28
|
Health Risk |
Pathogenic |
ANE syndrome, ANE syndrome |
| RS118204056 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204057 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204058 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204059 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204060 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204061 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204062 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204063 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204064 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204065 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204066 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204067 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204068 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204069 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204070 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204071 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204072 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204073 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204074 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204075 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204076 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204077 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204078 |
LPL
|
Health Risk |
Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204079 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204080 |
LPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperlipoproteinemia, type I |
| RS118204081 |
LPL
|
Health Risk |
Pathogenic |
LIPOPROTEIN LIPASE (OLBIA), Hyperlipoproteinemia |
| RS118204082 |
LPL
|
Health Risk |
Pathogenic |
Hyperlipoproteinemia, type I |
| RS118204084 |
PKLR
|
Health Risk |
Pathogenic |
Pyruvate kinase deficiency of red cells, Pyruvate kinase deficiency of red cells |
| RS118204085 |
PKLR
|
Health Risk |
Pathogenic |
Pyruvate kinase deficiency of red cells, Pyruvate kinase deficiency of red cells |
| RS118204089 |
PKLR
|
Health Risk |
Pathogenic |
Pyruvate kinase deficiency of red cells, Pyruvate kinase deficiency of red cells |
| RS118204090 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS118204091 |
ACOX1
|
Health Risk |
Likely pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS118204092 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS118204093 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Mitchell syndrome |
| RS118204094 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204095 |
HMBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute intermittent porphyria, Leukoencephalopathy |
| RS118204096 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Encephalopathy |
| RS118204097 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204098 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204099 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204100 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204101 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Encephalopathy |
| RS118204103 |
HMBS
|
Health Risk |
Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204104 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204105 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204107 |
HMBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204108 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204109 |
HMBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute intermittent porphyria, Encephalopathy |
| RS118204110 |
HMBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204111 |
HMBS
|
Health Risk |
Likely pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS118204112 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |